WallStreetZenWallStreetZen

NASDAQ: MGNX
Macrogenics Inc Stock Ownership - Who owns Macrogenics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Macrogenics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Thomas SpitznagelSr VP Technical Ops2025-02-155,520$2.56
$14.13kSell
Stephen L. EckChief Medical Officer2025-02-154,942$2.56
$12.65kSell
James KarrelsSVP CFO and Secretary2025-02-155,790$2.56
$14.82kSell
Jeffrey Stuart PetersSenior VP and General Counsel2025-02-155,147$2.56
$13.18kSell
Eric Blasius RisserChief Operating Officer2025-02-156,433$2.56
$16.47kSell
Beth Ann SmithVP Controller Treasurer2025-02-15423$2.56
$1.08kSell
Ezio BonviniSr VP Research CSO2025-02-084,311$2.60
$11.21kSell
Eric Blasius RisserChief Operating Officer2025-02-084,311$2.60
$11.21kSell
Stephen L. EckChief Medical Officer2025-02-083,312$2.60
$8.61kSell
Thomas SpitznagelSr VP Technical Ops2025-02-083,727$2.60
$9.69kSell

1 of 2

MGNX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MGNX insiders and whales buy or sell their stock.

MGNX Shareholders

What type of owners hold Macrogenics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Target N. V. Biotech15.74%9,929,963$16.29MInsider
Bellevue Group Ag15.74%9,929,963$16.29MInstitution
Armistice Capital LLC9.95%6,276,000$10.29MInstitution
Blackrock Inc8.02%5,057,175$8.29MInstitution
Vanguard Group Inc6.84%4,316,681$7.08MInstitution
Wasatch Advisors LP5.53%3,488,493$5.72MInstitution
Frazier Life Sciences Management LP5.03%3,175,665$5.21MInstitution
Millennium Management LLC4.54%2,864,721$4.70MInstitution
Tpg Group Holdings Sbs Advisors Inc3.50%2,208,762$3.62MInsider
Scott Koenig3.29%2,076,090$3.40MInsider

1 of 3

MGNX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MGNX70.26%29.74%Net SellingNet Selling
ENTX16.54%16.12%Net BuyingNet Buying
COYA26.57%12.80%Net Buying
ATOS23.17%14.77%Net BuyingNet Buying
GNLX14.08%6.43%Net Selling
View Top Biotech Stocks

Macrogenics Stock Ownership FAQ

Who owns Macrogenics?

Macrogenics (NASDAQ: MGNX) is owned by 88.72% institutional shareholders, 37.56% Macrogenics insiders, and 0.00% retail investors. Target N. V. Biotech is the largest individual Macrogenics shareholder, owning 9.93M shares representing 15.74% of the company. Target N. V. Biotech's Macrogenics shares are currently valued at $15.89M.

If you're new to stock investing, here's how to buy Macrogenics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.